Symbols / VREX Stock $12.07 -5.04% Varex Imaging Corporation

Healthcare • Medical Devices • United States • NMS
VREX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Sunny S. Sanyal
Exch · Country NMS · United States
Market Cap 505.97M
Enterprise Value 822.15M
Income -67.70M
Sales 854.40M
FCF (ttm) -15.69M
Book/sh 11.38
Cash/sh 3.00
Employees 2,400
Insider 10d —
IPO Jan 23, 2017
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 11.46
PEG 4.98
P/S 0.59
P/B 1.06
P/C —
EV/EBITDA 8.46
EV/Sales 0.96
Quick Ratio 1.67
Current Ratio 3.89
Debt/Eq 81.76
LT Debt/Eq —
EPS (ttm) -1.64
EPS next Y 1.05
EPS Growth —
Revenue Growth 4.90%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-02-10
ROA 3.62%
ROE -12.90%
ROIC —
Gross Margin 34.15%
Oper. Margin 7.35%
Profit Margin -7.92%
Shs Outstand 41.92M
Shs Float 41.20M
Insider Own 1.64%
Instit Own 98.61%
Short Float 3.71%
Short Ratio 5.61
Short Interest 1.38M
52W High 14.56
vs 52W High -17.13%
52W Low 6.76
vs 52W Low 78.55%
Beta 1.00
Impl. Vol. 40.51%
Rel Volume 0.67
Avg Volume 313.56K
Volume 211.34K
Target (mean) $18.40
Tgt Median $18.00
Tgt Low $16.00
Tgt High $22.00
# Analysts 5
Recom None
Prev Close $12.71
Price $12.07
Change -5.04%
About

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. It sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$18.40
Mean price target
2. Current target
$12.07
Latest analyst target
3. DCF / Fair value
$-6.74
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$12.07
Low
$16.00
High
$22.00
Mean
$18.40

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-11-19 reit B. Riley Securities Buy → Buy $16
2025-11-19 main Oppenheimer Outperform → Outperform $18
2025-08-08 main B. Riley Securities Buy → Buy $16
2025-02-07 main Oppenheimer Outperform → Outperform $23
2025-02-07 reit B. Riley Securities Buy → Buy $22
2024-08-23 init B. Riley Securities — → Buy $21
2023-11-15 main Oppenheimer Outperform → Outperform $30
2023-08-02 reit Oppenheimer Outperform → Outperform $42
2023-05-24 main Jefferies Hold → Hold $24
2022-10-12 init Jefferies — → Hold $24
2021-02-05 up Oppenheimer Perform → Outperform $41
2020-08-13 down Oppenheimer Outperform → Perform —
2020-05-13 main Jefferies — → Hold $25
2020-05-13 main Sidoti & Co. — → Buy $34
2020-05-13 down JP Morgan Overweight → Neutral —
2020-03-25 up JP Morgan Neutral → Overweight $32
2020-02-12 down Jefferies Buy → Hold $30
2019-11-13 main JP Morgan — → Neutral $32
2019-10-22 init Oppenheimer — → Outperform $40
2019-03-19 init Northland Capital Markets — → Outperform $42
News
RSS: Latest VREX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-20 KUNKEL JAY K. Director — 4,510 $11.14 $50,241
2026-02-09 GUERTIN TIMOTHY E Director — 8,483 — —
2026-02-09 TSINGOS CHRISTINE A Director — 8,483 — —
2026-02-09 ROSEBROUGH WALTER M JR Director — 10,339 — —
2026-02-09 BARDWELL KATHLEEN Director — 8,483 — —
2026-02-09 KUNKEL JAY K. Director — 8,483 — —
2026-02-09 CHERTOFF JOCELYN D. Director — 8,483 — —
2025-12-10 SANYAL SUNNY S Chief Executive Officer — 74,265 — —
2025-12-10 MAHESHWARI SHUBHAM Chief Financial Officer — 21,029 — —
2025-12-10 JONAITIS MARK S. Officer — 12,599 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Revenue
844.60
+4.14%
811.00
-9.22%
893.40
+3.96%
859.40
Operating Revenue
844.60
+4.14%
811.00
-9.22%
893.40
+3.96%
859.40
Cost Of Revenue
554.10
+0.00%
554.10
-8.12%
603.10
+4.72%
575.90
Reconciled Cost Of Revenue
554.10
+0.00%
554.10
-8.12%
603.10
+4.72%
575.90
Gross Profit
290.50
+13.08%
256.90
-11.51%
290.30
+2.40%
283.50
Operating Expense
224.40
-0.18%
224.80
+5.44%
213.20
+9.17%
195.30
Research And Development
91.10
+4.71%
87.00
+2.59%
84.80
+10.13%
77.00
Selling General And Administration
133.30
-3.27%
137.80
+7.32%
128.40
+8.54%
118.30
Total Expenses
778.50
-0.05%
778.90
-4.58%
816.30
+5.85%
771.20
Operating Income
66.10
+105.92%
32.10
-58.37%
77.10
-12.59%
88.20
Total Operating Income As Reported
-27.80
-186.60%
32.10
-58.37%
77.10
-12.59%
88.20
EBITDA
0.70
-98.89%
62.90
-31.03%
91.20
-20.35%
114.50
Normalized EBITDA
97.60
+54.68%
63.10
-41.90%
108.60
-6.38%
116.00
Reconciled Depreciation
27.20
-12.54%
31.10
-6.33%
33.20
-1.19%
33.60
EBIT
-26.50
-183.33%
31.80
-45.17%
58.00
-28.31%
80.90
Total Unusual Items
-96.90
-48350.00%
-0.20
+98.85%
-17.40
-1060.00%
-1.50
Total Unusual Items Excluding Goodwill
-96.90
-48350.00%
-0.20
+98.85%
-17.40
-1060.00%
-1.50
Special Income Charges
-93.90
-4571.43%
2.10
+112.80%
-16.40
0.00
Impairment Of Capital Assets
93.90
0.00
0.00
0.00
Restructuring And Mergern Acquisition
0.00
+100.00%
-2.10
0.00
0.00
Write Off
0.00
0.00
-100.00%
16.40
0.00
Net Income
-70.30
-44.06%
-48.80
-202.95%
47.40
+56.44%
30.30
Pretax Income
-59.20
-1284.00%
5.00
-84.03%
31.30
-29.66%
44.50
Net Non Operating Interest Income Expense
-27.00
-17.90%
-22.90
+10.55%
-25.60
+35.03%
-39.40
Interest Expense Non Operating
32.70
+22.01%
26.80
+0.37%
26.70
-26.65%
36.40
Net Interest Income
-27.00
-17.90%
-22.90
+10.55%
-25.60
+35.03%
-39.40
Interest Expense
32.70
+22.01%
26.80
+0.37%
26.70
-26.65%
36.40
Interest Income Non Operating
8.50
+16.44%
7.30
+97.30%
3.70
+825.00%
0.40
Interest Income
8.50
+16.44%
7.30
+97.30%
3.70
+825.00%
0.40
Other Income Expense
-98.30
-2240.48%
-4.20
+79.21%
-20.20
-369.77%
-4.30
Other Non Operating Income Expenses
0.90
+130.00%
-3.00
-114.29%
-1.40
-800.00%
0.20
Gain On Sale Of Security
-3.00
-30.43%
-2.30
-130.00%
-1.00
+33.33%
-1.50
Tax Provision
10.70
-79.92%
53.30
+421.08%
-16.60
-221.17%
13.70
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
-31.82%
0.00
Tax Effect Of Unusual Items
-20.35
-48350.00%
-0.04
+98.85%
-3.65
-690.91%
-0.46
Net Income Including Noncontrolling Interests
-69.90
-44.72%
-48.30
-200.84%
47.90
+55.52%
30.80
Net Income From Continuing Operation Net Minority Interest
-70.30
-44.06%
-48.80
-202.95%
47.40
+56.44%
30.30
Net Income From Continuing And Discontinued Operation
-70.30
-44.06%
-48.80
-202.95%
47.40
+56.44%
30.30
Net Income Continuous Operations
-69.90
-44.72%
-48.30
-200.84%
47.90
+55.52%
30.80
Minority Interests
-0.40
+20.00%
-0.50
+0.00%
-0.50
+0.00%
-0.50
Normalized Income
6.25
+112.85%
-48.64
-179.55%
61.15
+95.12%
31.34
Net Income Common Stockholders
-70.30
-44.06%
-48.80
-202.95%
47.40
+56.44%
30.30
Diluted EPS
-1.70
-45.30%
-1.17
-208.33%
1.08
+47.95%
0.73
Basic EPS
-1.70
-45.30%
-1.17
-197.50%
1.20
+57.89%
0.76
Basic Average Shares
41.40
+1.47%
40.80
+1.24%
40.30
+1.26%
39.80
Diluted Average Shares
41.40
+1.47%
40.80
-18.89%
50.30
+20.91%
41.60
Diluted NI Availto Com Stockholders
-70.30
-44.06%
-48.80
-202.95%
47.40
+56.44%
30.30
Average Dilution Earnings
—
0.00
-100.00%
6.20
0.00
Earnings From Equity Interest
-2.30
-130.00%
-1.00
+28.57%
-1.40
+53.33%
-3.00
Total Other Finance Cost
2.80
-17.65%
3.40
+30.77%
2.60
-23.53%
3.40
Line Item Trend 2023-09-30
Total Assets
1,249.60
Current Assets
658.30
Cash Cash Equivalents And Short Term Investments
193.90
Cash And Cash Equivalents
152.60
Other Short Term Investments
41.30
Receivables
163.60
Accounts Receivable
163.60
Gross Accounts Receivable
164.20
Allowance For Doubtful Accounts Receivable
-0.60
Inventory
277.50
Raw Materials
217.50
Work In Process
20.00
Finished Goods
40.00
Prepaid Assets
—
Other Current Assets
23.30
Total Non Current Assets
591.30
Net PPE
172.60
Gross PPE
412.10
Accumulated Depreciation
-239.50
Properties
0.00
Land And Improvements
8.30
Buildings And Improvements
159.10
Machinery Furniture Equipment
194.90
Construction In Progress
20.80
Other Properties
29.00
Goodwill And Other Intangible Assets
310.90
Goodwill
288.50
Other Intangible Assets
22.40
Investments And Advances
29.00
Long Term Equity Investment
29.00
Non Current Deferred Assets
41.30
Non Current Deferred Taxes Assets
41.30
Other Non Current Assets
37.50
Total Liabilities Net Minority Interest
668.60
Current Liabilities
162.80
Payables And Accrued Expenses
104.50
Payables
78.00
Accounts Payable
64.70
Current Accrued Expenses
26.50
Employee Benefits
5.20
Pensionand Other Post Retirement Benefit Plans Current
33.40
Total Tax Payable
13.30
Income Tax Payable
—
Current Debt And Capital Lease Obligation
5.30
Current Debt
1.50
Other Current Borrowings
1.50
Current Capital Lease Obligation
3.80
Current Deferred Liabilities
10.20
Current Deferred Revenue
10.20
Other Current Liabilities
9.40
Total Non Current Liabilities Net Minority Interest
505.80
Long Term Debt And Capital Lease Obligation
464.20
Long Term Debt
441.10
Long Term Capital Lease Obligation
23.10
Tradeand Other Payables Non Current
4.60
Non Current Deferred Liabilities
0.00
Non Current Deferred Taxes Liabilities
0.00
Other Non Current Liabilities
26.90
Stockholders Equity
567.70
Common Stock Equity
567.70
Capital Stock
0.40
Common Stock
0.40
Preferred Stock
0.00
Share Issued
40.53
Ordinary Shares Number
40.53
Treasury Shares Number
0.00
Additional Paid In Capital
450.40
Retained Earnings
118.10
Gains Losses Not Affecting Retained Earnings
-1.20
Minority Interest
13.30
Other Equity Adjustments
-1.20
Total Equity Gross Minority Interest
581.00
Total Capitalization
1,008.80
Working Capital
495.50
Invested Capital
1,010.30
Total Debt
469.50
Net Debt
290.00
Capital Lease Obligations
26.90
Net Tangible Assets
256.80
Tangible Book Value
256.80
Derivative Product Liabilities
4.90
Interest Payable
11.60
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Operating Cash Flow
41.70
-11.84%
47.30
-56.37%
108.40
+541.42%
16.90
Cash Flow From Continuing Operating Activities
41.70
-11.84%
47.30
-56.37%
108.40
+541.42%
16.90
Net Income From Continuing Operations
-69.90
-44.72%
-48.30
-200.84%
47.90
+55.52%
30.80
Depreciation Amortization Depletion
27.20
-12.54%
31.10
-6.33%
33.20
-1.19%
33.60
Depreciation
23.20
+9.43%
21.20
+8.72%
19.50
+2.63%
19.00
Amortization Cash Flow
4.00
-59.60%
9.90
-27.74%
13.70
-6.16%
14.60
Depreciation And Amortization
27.20
-12.54%
31.10
-6.33%
33.20
-1.19%
33.60
Amortization Of Intangibles
4.00
-59.60%
9.90
-27.74%
13.70
-6.16%
14.60
Other Non Cash Items
0.90
-59.09%
2.20
-60.71%
5.60
-66.86%
16.90
Stock Based Compensation
15.00
-1.96%
15.30
+13.33%
13.50
-3.57%
14.00
Asset Impairment Charge
97.70
+1893.88%
4.90
-77.73%
22.00
+243.75%
6.40
Deferred Tax
-0.50
-101.31%
38.10
+198.45%
-38.70
-6550.00%
0.60
Deferred Income Tax
-0.50
-101.31%
38.10
+198.45%
-38.70
-6550.00%
0.60
Operating Gains Losses
2.70
+35.00%
2.00
+25.00%
1.60
-38.46%
2.60
Change In Working Capital
-31.40
-1670.00%
2.00
-91.42%
23.30
+126.48%
-88.00
Change In Receivables
0.10
-98.51%
6.70
-31.63%
9.80
+154.14%
-18.10
Changes In Account Receivables
0.10
-98.51%
6.70
-31.63%
9.80
+154.14%
-18.10
Change In Inventory
-39.90
-704.55%
6.60
-67.33%
20.20
+123.76%
-85.00
Change In Prepaid Assets
-3.60
-209.09%
3.30
-52.86%
7.00
-32.04%
10.30
Change In Payables And Accrued Expense
6.30
+151.22%
-12.30
+23.13%
-16.00
-433.33%
4.80
Change In Accrued Expense
0.10
+101.10%
-9.10
-810.00%
-1.00
+93.29%
-14.90
Change In Payable
6.20
+293.75%
-3.20
+78.67%
-15.00
-176.14%
19.70
Change In Account Payable
6.20
+293.75%
-3.20
+78.67%
-15.00
-176.14%
19.70
Change In Other Working Capital
5.70
+347.83%
-2.30
-200.00%
2.30
—
Investing Cash Flow
10.30
+137.45%
-27.50
+38.75%
-44.90
+7.23%
-48.40
Cash Flow From Continuing Investing Activities
10.30
+137.45%
-27.50
+38.75%
-44.90
+7.23%
-48.40
Net PPE Purchase And Sale
-22.90
+14.87%
-26.90
-29.95%
-20.70
+2.82%
-21.30
Purchase Of PPE
-22.90
+14.87%
-26.90
-29.95%
-20.70
+2.82%
-21.30
Capital Expenditure
-22.90
+14.87%
-26.90
-29.95%
-20.70
+2.82%
-21.30
Net Investment Purchase And Sale
34.00
+8600.00%
-0.40
+98.55%
-27.60
-4.94%
-26.30
Purchase Of Investment
-31.40
+48.52%
-61.00
-9.12%
-55.90
-97.53%
-28.30
Sale Of Investment
65.40
+7.92%
60.60
+114.13%
28.30
+1315.00%
2.00
Net Business Purchase And Sale
0.00
-100.00%
0.90
+190.00%
-1.00
-190.91%
1.10
Purchase Of Business
—
0.00
+100.00%
-1.00
-66.67%
-0.60
Gain Loss On Sale Of Business
—
-2.10
0.00
0.00
Net Other Investing Changes
-0.80
+27.27%
-1.10
-125.00%
4.40
+331.58%
-1.90
Financing Cash Flow
-75.90
-2200.00%
-3.30
-1550.00%
-0.20
+99.16%
-23.80
Cash Flow From Continuing Financing Activities
-75.90
-2200.00%
-3.30
-1550.00%
-0.20
+99.16%
-23.80
Net Issuance Payments Of Debt
-75.00
-4587.50%
-1.60
+33.33%
-2.40
+91.84%
-29.40
Issuance Of Debt
126.90
0.00
0.00
0.00
Repayment Of Debt
-201.90
-12518.75%
-1.60
+33.33%
-2.40
+91.84%
-29.40
Long Term Debt Issuance
126.90
0.00
0.00
0.00
Long Term Debt Payments
-201.90
-12518.75%
-1.60
+33.33%
-2.40
+91.84%
-29.40
Net Long Term Debt Issuance
-75.00
-4587.50%
-1.60
+33.33%
-2.40
+91.84%
-29.40
Proceeds From Stock Option Exercised
3.30
-13.16%
3.80
-7.32%
4.10
-52.87%
8.70
Net Other Financing Charges
-4.20
+23.64%
-5.50
-189.47%
-1.90
+38.71%
-3.10
Changes In Cash
-23.90
-244.85%
16.50
-73.93%
63.30
+214.47%
-55.30
Effect Of Exchange Rate Changes
0.60
+700.00%
-0.10
-200.00%
0.10
+150.00%
-0.20
Beginning Cash Position
170.40
+10.65%
154.00
+69.98%
90.60
-37.99%
146.10
End Cash Position
147.10
-13.67%
170.40
+10.65%
154.00
+69.98%
90.60
Free Cash Flow
18.80
-7.84%
20.40
-76.74%
87.70
+2093.18%
-4.40
Interest Paid Supplemental Data
31.30
+13.41%
27.60
+0.73%
27.40
-7.12%
29.50
Income Tax Paid Supplemental Data
18.60
-7.92%
20.20
+20.96%
16.70
+659.09%
2.20
Earnings Losses From Equity Investments
2.70
+35.00%
2.00
+25.00%
1.60
-38.46%
2.60
Sale Of Business
0.00
-100.00%
0.90
0.00
-100.00%
1.70
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category